ECTRIMS 2025: Frexalimab helps control MS for 2.5 years in study – Multiple Sclerosis News Today


ECTRIMS 2025: Frexalimab helps control MS for 2.5 years in study  Multiple Sclerosis News Today


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *